Aligos Therapeutics Inc (ALGS)

Aligos Therapeutics Inc has recorded no insider trading activity within the last 90 days. The most recent transaction occurred on October 25, 2023, involving a purchase of shares. Prior to this, significant buying activity was observed in October 2020 by various institutional investors and insiders.
Ticker: ALGS Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 25 Oct 2023
Value US$4,314,490.30 | Price 11.17 | Shares 76,402 (+2.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-10-27 2023-10-25 B Purchase Non-Executive Director Large shareholder
76,402 +2.1%
11.17
US$4,314,490
76,402 +2.1% 11.17 US$4,314,490
2020-10-22 2020-10-20 B Purchase Large shareholder
30,973 +30.4%
462.52
US$3,016,277
30,973 +30.4% 462.52 US$3,016,277
2020-10-20 2020-10-20 B Purchase Non-Executive Director
83,694 -13.4%
467.89
US$4,563,346
83,694 -13.4% 467.89 US$4,563,346
2020-10-20 2020-10-20 B Purchase Large shareholder
200,000 +30.2%
15.00
US$3,000,000
200,000 +30.2% 15.00 US$3,000,000
2020-10-20 2020-10-20 B Purchase Large shareholder
66,733 +18.4%
15.00
US$1,000,995
66,733 +18.4% 15.00 US$1,000,995
2020-10-20 2020-10-20 B Purchase Large shareholder
483,267 +18.4%
15.00
US$7,249,005
483,267 +18.4% 15.00 US$7,249,005